| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2538997 | Fitoterapia | 2011 | 5 Pages |
A new oxysporidinone analogue (1) and a new 3-hydroxyl-2-piperidinone derivative (2), along with the known compounds (−)-4,6′-anhydrooxysporidinone (3), (+)-fusarinolic acid (4), gibepyrone D (5), beauvercin (6),cerevisterol (7), fusaruside (8), and (2S,2′R,3R,3′E,4E,8E)-1-O-D-glucopyranosyl-2-N-(2′-hydroxy-3′-octadecenoyl)-3-hydroxy-9-methyl-4,8-sphingadienine (9) were isolated from Fusarium oxysporum. Compounds 1–9 were evaluated for cytotoxicity using the MTT method against cancer cell lines, PC-3, PANC-1, and A549. Beauvericin showed cytotoxicity against PC-3, PANC-1, and A549 with IC50 value of 49.5 ± 3.8, 47.2 ± 2.9, and 10.4 ± 1.6 μM, respectively. Beauvericin also exhibited anti-bacterial activity towards methicillin-resistant Staphylococcus aureus (MIC = 3.125 μg/mL) and Bacillus subtilis (MIC = 3.125 μg/mL).
Graphical abstractA new oxysporidinone analogue (1) and a new 3-hydroxyl-2-piperidinone derivative (2), along with seven known compounds were isolated from the solid culture of Fusarium oxysporum. Their cytotoxic activity against a panel of three human cancer cell lines, PC-3, PANC-1, and A549 were evaluated by MTT method.Figure optionsDownload full-size imageDownload as PowerPoint slide
